Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (CTRI/2026/09/116875) titled 'UV-A Protection of Ectobarrier Sunscreen SPF 50plus PA 4plus' on Sept. 2.
Study Type: PMS
Study Design:
Single Arm Study Method of generating randomization sequence:Not Applicable Method of allocation concealment:Not Applicable Blinding and masking:Open Label
Primary Sponsor: Jawa Pharmaceuticals India Pvt. Ltd.
Intervention:
Intervention1: Test Product: Ectobarrier Sunscreen SPF 50+ PA++++: Quantity 2 mg per sq.cm Route of administration: Topical Frequency: Once Duration: 24 hour
Control Intervention1: Not Applicable: Not Applicable
Recruitment Status: Not Recruiting
Phase: Post Marketing Surve...